Fixed Triple Therapy Improves Lung Function in Asthma Patients
(MedPage Today) -- Fixed-dose triple therapy with fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) improved lung function in adults whose asthma was uncontrolled with an inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA...
Read more »